It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Duchenne muscular dystrophy (DMD) is a severe rare neuromuscular disorder caused by mutations in the X-linked dystrophin gene. Several mutations have been identified, yet the full mutational spectrum, and their phenotypic consequences, will require genotyping across different populations. To this end, we undertook the first detailed genotype and phenotype characterization of DMD in the Bangladeshi population. We investigated the rare mutational and phenotypic spectrum of the DMD gene in 36 DMD-suspected Bangladeshi participants using an economically affordable diagnostic strategy involving initial screening for exonic deletions in the DMD gene via multiplex PCR, followed by testing PCR-negative patients for mutations using whole exome sequencing. The deletion mapping identified two critical DMD gene hotspot regions (near proximal and distal ends, spanning exons 8–17 and exons 45–53, respectively) that comprised 95% (21/22) of the deletions for this population cohort. From our exome analysis, we detected two novel pathogenic hemizygous mutations in exons 21 and 42 of the DMD gene, and novel pathogenic recessive and loss of function variants in four additional genes: SGCD, DYSF, COL6A3, and DOK7. Our phenotypic analysis showed that DMD suspected participants presented diverse phenotypes according to the location of the mutation and which gene was impacted. Our study provides ethnicity specific new insights into both clinical and genetic aspects of DMD.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 NeuroGen Healthcare, Genetics and Genomic Medicine Centre (GGMC), Dhaka, Bangladesh; Bangladesh Shishu Hospital and Institute, Dhaka, Bangladesh
2 NeuroGen Healthcare, Genetics and Genomic Medicine Centre (GGMC), Dhaka, Bangladesh
3 Mohammed Bin Rashid University of Medicine and Health Sciences, Center for Applied and Translational Genomics (CATG), Dubai, UAE (GRID:grid.510259.a) (ISNI:0000 0004 5950 6858)
4 Bangladesh Shishu Hospital and Institute, Dhaka, Bangladesh (GRID:grid.510259.a)
5 NeuroGen Healthcare, Genetics and Genomic Medicine Centre (GGMC), Dhaka, Bangladesh (GRID:grid.510259.a)
6 NeuroGen Healthcare, Genetics and Genomic Medicine Centre (GGMC), Dhaka, Bangladesh (GRID:grid.510259.a); GenomeArc Inc., Mississauga, Canada (GRID:grid.510259.a)
7 Holy Family Red Crescent Medical College and Hospital, Department of Biochemistry, Dhaka, Bangladesh (GRID:grid.510259.a)
8 University of Massachusetts Chan Medical School, Department of Genomics and Computational Biology, Worcester, USA (GRID:grid.168645.8) (ISNI:0000 0001 0742 0364); University of Massachusetts Chan Medical School, Department of Molecular, Cell and Cancer Biology, Worcester, USA (GRID:grid.168645.8) (ISNI:0000 0001 0742 0364)
9 NeuroGen Healthcare, Genetics and Genomic Medicine Centre (GGMC), Dhaka, Bangladesh (GRID:grid.168645.8)
10 Newcastle University, Biosciences Institute, Newcastle upon Tyne, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212)
11 Mohammed Bin Rashid University of Medicine and Health Sciences, Center for Applied and Translational Genomics (CATG), Dubai, UAE (GRID:grid.510259.a) (ISNI:0000 0004 5950 6858); GenomeArc Inc., Mississauga, Canada (GRID:grid.510259.a)